Evaluating side effects of palliative radiotherapy in cancer patients
Evaluation of Toxicities in Patients Treated With Palliative Radiotherapy at Policlinico Sant Orsola of Bologna - patieNts treAted wIth palliatiVe radiothErapy - NAIVE
This study tests how well palliative radiotherapy can help cancer patients with symptoms like pain and bleeding feel better.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 7000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | IRCCS Azienda Ospedaliero-Universitaria di Bologna Academic / other |
| Drugs / interventions | radiation |
| Locations | 1 site (Bologna) |
| Trial ID | NCT06760806 on ClinicalTrials.gov |
What this trial studies
This study aims to assess the outcomes of palliative radiotherapy in patients with malignant neoplasms, focusing on symptom resolution or alleviation. It examines various treatment settings, dosages, and techniques used for both newly diagnosed and previously treated tumors at the Radiotherapy Unit of Sant Orsola Hospital. The study will analyze the effectiveness of radiotherapy in alleviating symptoms such as pain, bleeding, and obstruction, particularly in patients with bone metastases. By understanding these outcomes, the study seeks to improve palliative care strategies for cancer patients.
Who should consider this trial
Good fit: Ideal candidates include adult patients with a new or previous diagnosis of malignant neoplasm who are receiving palliative radiotherapy.
Not a fit: Patients who choose not to undergo radiotherapy or are enrolled in other studies may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance the quality of life for cancer patients by optimizing palliative radiotherapy treatments.
How similar studies have performed: Other studies have shown that palliative radiotherapy can effectively alleviate cancer-related symptoms, indicating a potential for success in this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * adult patients of either sex with a new or previous diagnosis of malignant neoplasm since 1st January 2000 * patients treated with paliative radiotherapy * obtaining of informed consent Exclusion Criteria: * adult patients of either sex with a new or previous diagnosis of malignant neoplasm who choose not to undergo radiotherapy treatment * patients enrolled in other studies * pregnant or breastfeeding women
Where this trial is running
Bologna
- IRCCS Azienda Ospedaliero - Universitaria di Bologna — Bologna, Italy (Recruiting)
Study contacts
- Principal investigator: Alessio Giuseppe Morganti, MD — IRCCS Azienda Ospedaliero-Universitaria di Bologna
- Study coordinator: Alessio Giuseppe Morganti, MD
- Email: alessio.morganti2@unibo.it
- Phone: 0512143564
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.